Resmed Inc. buy Morgan Stanley
Start price
27.10.23
/
50%
€126.35
Target price
27.10.24
€160.06
Performance (%)
70.02%
Price
04.10.24
€213.00
Summary
This prediction is currently active. With a performance of 70.02% the BUY prediction by Morgan_Stanley is a big success. Dividends of €1.82 are taken into consideration when calculating the performance. This prediction currently runs until 27.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Resmed Inc. | -0.514% | -0.514% |
iShares Core DAX® | -1.114% | 5.062% |
iShares Nasdaq 100 | 1.816% | 9.828% |
iShares Nikkei 225® | 2.113% | 8.218% |
iShares S&P 500 | 2.038% | 7.448% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $169.00 price target on the stock, down previously from $180.00.
Ratings data for RMD provided by MarketBeat